MFN2 and metabolic dysfunction-associated steatohepatitis: Mfn2 ablation in the liver causes endoplasmic reticulum (ER)-mitochondrial phosphatidylserine transfer defects, leading to a non-alcoholic steatohepatitis (NASH)-like phenotype and liver cancer13.